1. Cavan DHJ, Linnenkamp U, Makaroff L, Magliano D, Ogurtrstova K, Shaw J. Diabetes and cardiovascular disease. International Diabetes Federation 2016;1–12.
http://www.idforg/cvd
. Accessed 9 Aug 2018.
2. Feingold KR, Grunfeld C. Obesity and dyslipidemia. In: De Groot LJ, Chrousos G, Dungan K, et al., editors. Endotext. South Dartmouth (MA):
MDText.com
, Inc., 2000. Acessed 10 April 2018.
3. Srivastava RA, Srivastava N. Search for obesity drugs: targeting central and peripheral pathways. Curr Med Chem Immunol Endocr Metab Agents. 2004;4:75–90.
4. Kaur J. A comprehensive review on metabolic syndrome. Cardiol Res Pract. 2014;2014:943162.
5. Zafar U, Khaliq S, Ahmad HU, Manzoor S, Lone KP. Metabolic syndrome: an update on diagnostic criteria, pathogenesis, and genetic links. Hormones (Athens, Greece). 2018;17:299–313.